Investing is about picking the right stocks and avoiding the wrong ones. While some companies are capitalizing on powerful ...

After years of being stuck behind the curtain of prohibition, the legal cannabis industry is finally thriving. In October, Canada became the first industrialized country, and the second overall behind ...

Download the Complete Report Here By Karen Roman Our favorite plug’s strategy is paying off: Net revenue is increasing and ...

Aurora Cannabis (NASDAQ: ACB) stock leapt 14.5% "higher" (get it? Marijuana? High?) through 11:55 a.m. ET Friday on some positive marijuana news out of the White House. As The Washington Post reports, ...

Earnings call Aurora Cannabis reported Q1 FY2025 revenue of CAD $83.4M, up 12% YoY, led by 24% growth in international medical cannabis. Adjusted EBITDA rose 87% YoY to CAD $4.9M, and the company ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis ACB sits at the intersection of a shifting regulatory landscape as the Trump administration moves to reclassify marijuana. While the decision marks a constructive step for the cannabis ...

EDMONTON, AB, Feb. 4, 2026 /CNW/ - Aurora Cannabis Inc. (ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 ...

Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. First, ...

The Washington Post reports that President Trump will reschedule marijuana as a Schedule III drug. Marijuana is already legal in Canada, but Aurora Cannabis can't seem to make a profit off of it.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-fiscal-2026-second-quarter-results-302604871.html ...